Champions Oncolog
(CSBR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 04/30
| 04-2010 | 04-2009 | 04-2008 | 04-2007 | 04-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,923 | -2,242 | -411 | -170 | -144 |
| Depreciation Amortization | 32 | 4 | N/A | 11 | N/A |
| Accounts receivable | -46 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | -471 | 881 | 72 | 17 | -36 |
| Other Working Capital | 1 | 602 | 586 | 81 | 67 |
| Other Operating Activity | 1,307 | -133 | 545 | -16 | 19 |
| Operating Cash Flow | $-2,100 | $-888 | $792 | $-79 | $-94 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 1,017 | -1,017 | N/A | N/A | N/A |
| PPE Investments | -76 | -69 | N/A | N/A | N/A |
| Net Acquisitions | N/A | N/A | 471 | N/A | 10 |
| Purchase Sale Intangibles | N/A | -57 | -47 | N/A | N/A |
| Other Investing Activity | 0 | -64 | -47 | 0 | 0 |
| Investing Cash Flow | $941 | $-1,150 | $424 | $N/A | $10 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | -44 | 44 | N/A |
| Common Stock Issued | 2,225 | 57 | 2,533 | 38 | N/A |
| Common Stock Repurchased | -218 | N/A | N/A | N/A | N/A |
| Financing Cash Flow | $2,007 | $57 | $2,489 | $82 | $N/A |
| Exchange Rate Effect | -4 | N/A | N/A | N/A | N/A |
| Beginning Cash Position | 1,728 | 3,709 | 4 | 1 | 85 |
| End Cash Position | 2,572 | 1,728 | 3,709 | 4 | 1 |
| Net Cash Flow | $844 | $-1,981 | $3,705 | $3 | $-84 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,100 | -888 | 792 | -79 | -94 |
| Capital Expenditure | -84 | -69 | N/A | N/A | N/A |
| Free Cash Flow | -2,184 | -957 | 792 | -79 | -94 |